Thursday, October 25, 2018

Amgen Slashes the Price of a Promising Cholesterol Drug

The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)